Incannex Healthcare Inc. IXHL
3.32
(0.08)
(2.35%)
as of 25 Sep
- Market cap
- $40.7M
- P/E
- 0.0×
Follow IXHL
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
| (117.17%) | (130.42%) | (114.52%) | (381.09%) |
+8 more TTM periods Free account |
|
| (100.36%) | (112.64%) | (101.03%) | (250.09%) | ||
ROIC |
(2,022.08%) | (390.46%) | (407.88%) | 0.00% | |
Return on Tangible Assets |
(61.90%) | (66.22%) | (62.32%) | (355.05%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(1.44) | (1.58) | (1.88) | (10.92) | |
Free Cash Flow |
(17.73) | (18.43) | (19.44) | (12.52) | |
Capital Expenditures |
(0.01) | (0.01) | (0.01) | (0.01) | |
| Other line items | |||||
Cash ROIC |
(11.84%) | (12.92%) | (12.93%) | (44.02%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.37 | 0.38 | 0.41 | 0.27 | |
Depreciation/Fixed assets |
5.34 | 1.68 | 1.48 | 1.08 | |
Capex/Depreciation |
(0.04) | (0.03) | (0.04) | (0.04) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.44) | (1.58) | (1.88) | (10.91) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates